Write a 3-4 page paper: From your clinical site, choose a core measure to write a 3 – 4 page paper about.Include a description of the measure, how it is evaluated, and the results.Do you have recommen

******** Site **** **************** ******* are *********** ********** ************ due ** *** ******* interaction ** ******* ***** ****** ********** *** ***** ******* The ******* *************** ******* **** a **** ********* transmission *********** which ** *** ********** can ********** ****** ******* **** and ******** safety *** clinical **** handles bloodlines *** ******* hence *** **** *** *** implementation of ******* ******** to ********* *** ********* ** *** ************ Therefore ***** members' training ** vital ** they learn ***** *** **** infection ******* ********** *** ********* *** ***** ******** *** treatment ****** as * ******** *************** ****** and *********** *** importance ** tracking *** ********** *** *********** ********* ******* **** ********** * ********** ******** ****** ********** is critical to ****** ************** *** *** ********* of ******* **** *** ******** site qualifies ** * *************** ****** ** *** technologies **** **** as ********** **** and ******** ***** are advanced ******* **** **** **** *** ********** *** ******* of ***** samples *** effectiveness of the facility in ************ ****** and *********** ******* spread is dependent ** *** *** ************ ******** **** the ************ as ***** by ******** ** al ****** in ***** ******** Trained ******* ************* *** entrusted **** ******** ****** ********* to ******* *** ************* ** *** center *** guarantee **** *** ************ *** ******* at *** times *** **** ******** ** ***** ******* *** care ********* ** critical ** the ********* ** clinical ******** ********* ****** communication ******** *** ********* ** all ********* are critical for ***** reduction and safety ********* ** ****** ** Hessels ** ** (2023) *** ****** **** has ****** *** ******** ************* ******** which depend on ***** factors *** ********* to *** ****** ********** and ****** protocolsInfection ******** * **** IssueIn **** ******** ********* ******* ** * ******** ** *** **** ** ************ is quite high due ** *** *** ** ********** *** ******* ** *** center ** left ** ******* ************ the ********** ** *********** *********** ********* such ** HIV Hepatitis * and * is exponentially **** ** ****** ********** ** healthcare-associated ********** ****** during a ***** ** ****** **** it is prudent ** ********* **** ******** ** infection ******* ***** members are **** ** **** if **** **** the ********* **** ** *** as **** *** exposed ** ************ ********* If there are ******** site lags ** *** ************** ** ********* control ********* *** **** ** ******* transmission ** **** and **** may ***** the ******* of **** and *********** **************** Infection Control ************* ******** **** ******** adheres ** ****** ********** ** they have ********* ********* ***** ********** ******* *********** **** ******* ********** ******* ********* *** ********* ***** ***** **** ******** piercing objects *** ** the ***** ***** factor *********** *** surest improvement ****** ** ****** ** workers' ****** ******** *********** through ******* ******** ******** **** ** ********** requires ******** **** ******* key ****** ***** as ********* **************** ******** ********** The ******* was *********** ** OSHA ** * ******** ********* *** ********** *** ****** hazardous ********* such ** ***** ** their ******* ****** ** **** (Hessels ** ** ***** ** provides ********** ** *** to ***** exposure and the **** response if ** ******** *** to ************* Precaution: *** center ****** have well-labeled ********* and ******** ********* ******** on the clinical **** which ********* routine precaution ********** ** ****** ********* caution **** handling ***** ********* ****** ******* ********** **** and ********* **** ******* ** * ********* when interacting **** ************** technique: *** ******* ******** ********** *** ******** ** clinicians ** *** ************* protocols ****** when undertaking ******** procedures **** ** ********** or ** (intravenous) therapy ********* ***** Management: ** ** ******* ** ********* staff ******** ******* ** ***** *********** *** ******** of ************ materials and ***** ***** *** ************* ************ and ******** ******** ********* ************ ******** ***** Training on ********* Control ************ ******* aims ** train ********** ** *** latest infection ******* ********* ** their ******** ******** Some ** *** programs ******* ******* aseptic ********** ***** ********** *** *********** ******** standards Upon ******** the staff ******* will ******** *** **** ** HIAs ****** workEvaluation ProcessThere are ******* ways ** ***** *** ****** *** ****** *** effectiveness ** *** training ******** including ********* and ******** ********** of **** *** clients who ***** *** center *** ********** can also ******** ******* ***** staff ***** ******* to ******** the ************* ** the training ******* **** *** **** ** ********* ** established hygiene protocols ** assessed *** ********** ****** ** ******* out before *** ***** the training ** **** *** ********* ***************** ****** evaluation *** management ***** ********* an ******** ** compliance ****** *** *********** ****** *** **** ***** also ******** * ******** ** ***** ** **** over * given ****** ** the ******** site ***** *** ********** ********** staff might **** project ********* ********* ** ********* ******* *********************** *** *********** The clinic ****** **** it a habit ** ************ ****** the competency of *** ***** ******* to ********* *** **** *** ********** ******** ******** **** should *** ******** **** ******* staff members ** *********** ***** ** *** ****** ********** ** ************ ******* ********** ******** Further *** ********** should ********** * ******* of accurate ******* ** allowing ***** members ** ****** ** ****** ** ********* ** ******* ********* ******* **** of repercussions ReferencesAlhumaid S Mutair A * ***** * * Alsuliman * ***** * * Rabaan A * ********* * * & ******** * (2021) ********* ** ********* ********** *** control ***** ********** ******* *** factors *********** *********** * ********** ****** Antimicrobial ********** *** ********* Control ***** https://doiorg/101186/s13756-021-00957-0Hessels * * *** J ******* * T ***** ****** * ****** ****** ** patient safety ******* on ********* prevention ********* *** ********** ****** *** ******* ******** ******** ******* ** ********* ******* 51(5) ********* **************************************